Indications and Purposes
| 1 Indications And Usage Koselugo Is Indicated For The Treatment Of Pediatric Patients 2 Years Of Age And Older With Neurofibromatosis Type 1 (Nf1) Who Have Symptomatic, Inoperable Plexiform Neurofibromas (Pn). Koselugo Is A Kinase Inhibitor Indicated For The Treatment Of Pediatric Patients 2 Years Of Age And Older With Neurofibromatosis Type 1 (Nf1) Who Have Symptomatic, Inoperable Plexiform Neurofibromas (Pn). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Selumetinib |
|
ZINC31773258 |